Publicaciones (28) Publicaciones en las que ha participado algún/a investigador/a

2024

  1. Barriers and facilitators of health professionals in adopting digital health-related tools for medication appropriateness: A systematic review

    Digital Health, Vol. 10

  2. Bioguided Assay of Polyphenols Isolated from Medicinal Mayan Species and its Activity Against Leishmania mexicana

    Pharmacognosy Journal, Vol. 16, Núm. 1, pp. 174-180

  3. Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry

    Therapeutic Advances in Gastroenterology, Vol. 17

  4. Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA Registry

    Journal of Crohn's & colitis, Vol. 18, Núm. 1, pp. 65-74

  5. Comparing AGS Beers 2019, STOPP version 2, and EU(7)-PIM list in Portuguese older adults in primary health care

    European Journal of Clinical Pharmacology, Vol. 80, Núm. 4, pp. 603-612

  6. Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study

    United European Gastroenterology Journal

  7. Current drug strategies for the treatment and control of schistosomiasis

    Expert Opinion on Pharmacotherapy, Vol. 25, Núm. 4, pp. 409-420

  8. Cytotoxic Cyclolignans Obtained by the Enlargement of the Cyclolignan Skeleton of Podophyllic Aldehyde, a Selective Podophyllotoxin-Derived Cyclolignan

    Molecules, Vol. 29, Núm. 7

  9. Editorial: Sequencing rescue therapy for acute severe ulcerative colitis—Ready for revision? Authors' reply

    Alimentary Pharmacology and Therapeutics

  10. Effect of uric acid reduction on chronic kidney disease. Systematic review and meta-analysis

    Frontiers in Pharmacology, Vol. 15

  11. Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)

    Alimentary Pharmacology and Therapeutics, Vol. 59, Núm. 10, pp. 1248-1259

  12. Experimental structure based drug design (SBDD) applications for anti-leishmanial drugs: A paradigm shift?

    Medicinal Research Reviews, Vol. 44, Núm. 3, pp. 1055-1120

  13. Functional proteomics based on protein microarray technology for biomedical research

    Advances in Protein Chemistry and Structural Biology (Academic Press Inc.), pp. 49-65

  14. Increased prevalence of migraine in women with inflammatory bowel disease: A cross-sectional study

    Cephalalgia : an international journal of headache, Vol. 44, Núm. 3

  15. Insights into the Neuroprotective Potential of Epicatechin: Effects against Aβ-Induced Toxicity in Caenorhabditis elegans

    Antioxidants, Vol. 13, Núm. 1

  16. Insights into the phenolic composition and in vitro bioactivity of cardoon capitulum: A nutraceutical-oriented valorization study

    Food Chemistry, Vol. 435

  17. Magnesium and manganese induced changes on chemical, nutritional, antioxidant and antimicrobial properties of the pansy and Viola edible flowers

    Food Chemistry, Vol. 438

  18. Magnitude and Determinants of Long-term Use of Proton Pump Inhibitors Among Portuguese Older Adults in Primary Health Care

    Clinical Therapeutics, Vol. 46, Núm. 2, pp. e54-e58

  19. Modulatory effect of Andean blackberry polyphenols on genes related to antioxidant and inflammatory responses, the NLRP3 inflammasome, and autophagy

    Journal of Berry Research, Vol. 14, Núm. 1, pp. 41-59

  20. New benzimidazole derivative compounds with in vitro fasciolicidal properties

    Parasites and Vectors, Vol. 17, Núm. 1